Cargando…

Identification of High-Affinity Small Molecule Targeting IDH2 for the Clinical Treatment of Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is symbolized by an increase in the number of myeloid cells in the bone marrow and an arrest in their maturation, frequently resulting in hematopoietic insufficiency (granulocytopenia, thrombocytopenia, or anemia) with or without leukocytosis either by a predominance of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sweta, Jajoriya, Khandelwal, Ravina, Srinitha, Sivaraj, Pancholi, Rashi, Adhikary, Ritu, Ali, Meer Asif, Nayarisseri, Anuraj, Vuree, Sugunakar, Singh, Sanjeev Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852809/ https://www.ncbi.nlm.nih.gov/pubmed/31450897 http://dx.doi.org/10.31557/APJCP.2019.20.8.2287

Ejemplares similares

An In silico Approach to Identify High Affinity Small Molecule Targeting m-TOR Inhibitors for the Clinical Treatment of Breast Cancer
por: Patidar, Khushboo, et al.
Publicado: (2019)

Identification of Potent VEGF Inhibitors for the Clinical Treatment of Glioblastoma, A Virtual Screening Approach
por: Yadav, Mohini, et al.
Publicado: (2019)

Design of PD-L1 inhibitors for lung cancer
por: Udhwani, Trishang, et al.
Publicado: (2019)

Virtual Screening of IL-6 Inhibitors for Idiopathic Arthritis
por: Shukla, Palak, et al.
Publicado: (2019)

Genome analysis of biosurfactant producing bacterium, Bacillus tequilensis
por: Nayarisseri, Anuraj, et al.
Publicado: (2023)

FLT3 inhibitor design using molecular docking based virtual screening for acute myeloid leukemia
por: Gokhale, Padmini, et al.
Publicado: (2019)

Lipid-based nanoparticles for treatment of cancer()
por: Sheoran, Sumit, et al.
Publicado: (2022)

Screening, isolation and characterization of biosurfactant producing Bacillus subtilis strain ANSKLAB03
por: Nayarisseri, Anuraj, et al.
Publicado: (2018)

Molecular docking approaches in identification of High affinity inhibitors of Human SMO receptor
por: Akare, Uday Raj, et al.
Publicado: (2014)

Diabetes mellitus susceptibility with varied diseased phenotypes and its comparison with phenome interactome networks
por: Rout, Madhusmita, et al.
Publicado: (2022)

Alkyloxy carbonyl modified hexapeptides as a high affinity compounds for Wnt5A protein in the treatment of psoriasis
por: Kelotra, Ankit, et al.
Publicado: (2014)

IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
por: Cerchione, Claudio, et al.
Publicado: (2021)

Biodegradation effects of o-cresol by Pseudomonas monteilii SHY on mustard seed germination
por: Krishnan, Shainy Nhattuketty, et al.
Publicado: (2018)

Identification and characterization of cresol degrading Pseudomonas monteilii strain SHY from Soil samples
por: Krishnan, Shainy Nhattuketty, et al.
Publicado: (2018)

Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm
por: Issa, Ghayas C., et al.
Publicado: (2021)

Implications of a novel Pseudomonas species on low density polyethylene biodegradation: an in vitro to in silico approach
por: Bhatia, Mayuri, et al.
Publicado: (2014)

Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
por: Gupta, Charu, et al.
Publicado: (2020)

Concurrent inhibition of IDH and methyltransferase maximizes therapeutic efficacy in IDH mutant acute myeloid leukemia
por: Zeng, Zhihong, et al.
Publicado: (2021)

Screening, Purification and Characterization of Protease Inhibitor from Capsicum frutescens
por: Mohan, Manju, et al.
Publicado: (2018)

Novel Multiplex Bead-Based Assay for Detection of IDH1 and IDH2 Mutations in Myeloid Malignancies
por: Shivarov, Velizar, et al.
Publicado: (2013)

CLINICAL AND BIOLOGICAL IMPLICATIONS OF ANCESTRAL AND NON-ANCESTRAL IDH1 AND IDH2 MUTATIONS IN MYELOID NEOPLASMS
por: Molenaar, Remco J., et al.
Publicado: (2015)

Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia: Emerging Options and Pending Questions
por: Wouters, Bas J.
Publicado: (2021)

Molecular dynamic simulations reveal suboptimal binding of salbutamol in T164I variant of β2 adrenergic receptor
por: Bandaru, Srinivas, et al.
Publicado: (2017)

Design of novel JAK3 Inhibitors towards Rheumatoid Arthritis using molecular docking analysis
por: Jain, Divya, et al.
Publicado: (2019)

IDH1/2 mutations in acute myeloid leukemia
por: Byun, Ja Min, et al.
Publicado: (2022)

P454: ACUTE MYELOID LEUKEMIA (AML) WITH IDH1 AND IDH2 MUTATIONS CAN BE EFFECTIVELY RISK STRATIFIED BASED ON THE PRESENCE ADVERSE RISK GENOMIC FEATURES.
por: Bhide, Aniket, et al.
Publicado: (2023)

Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia
por: Chaturvedi, Anuhar, et al.
Publicado: (2020)

Ivosidenib: IDH1 Inhibitor for the Treatment of Acute Myeloid Leukemia
por: Merchant, Shelby L., et al.
Publicado: (2019)

The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia
por: Zhuang, Xiaomei, et al.
Publicado: (2022)

EDITORIAL: Improving Neuropharmacology using Big Data, Machine Learning and Computational Algorithms
por: Shameer, Khader, et al.
Publicado: (2017)

Immuno-phenotyping of IDH-mutant grade 3 astrocytoma and IDH-wildtype glioblastoma reveals specific differences in cells of myeloid origin
por: Raghavan, Jayashree V., et al.
Publicado: (2021)

Towards Understanding the Key Signature Pathways Associated from Differentially Expressed Gene Analysis in an Indian Prostate Cancer Cohort
por: Shukla, Nidhi, et al.
Publicado: (2023)

Molecular Docking and Pharmacological Investigations of Rivastigmine-Fluoxetine and Coumarin–Tacrine hybrids against Acetyl Choline Esterase
por: Babitha, Pallikkara Pulikkal, et al.
Publicado: (2015)

Insights from the predicted epitope similarity between Mycobacterium tuberculosis virulent factors and its human homologs
por: Gutlapalli, Venkata Ravi, et al.
Publicado: (2015)

Enasidenib: An Oral IDH2 Inhibitor for the Treatment of Acute Myeloid Leukemia
por: Myers, Rebecca A., et al.
Publicado: (2018)

Highly Sensitive Detection of IDH2 Mutations in Acute Myeloid Leukemia
por: Petiti, Jessica, et al.
Publicado: (2020)

Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro
por: Sarkaria, Shawn M., et al.
Publicado: (2014)

Efficacy and safety of FDA-approved IDH inhibitors in the treatment of IDH mutated acute myeloid leukemia: a systematic review and meta-analysis
por: Chen, Xiu, et al.
Publicado: (2023)

Molecular docking analysis of RN18 and VEC5 in A3G-Vif inhibition
por: Sinha, Chanda, et al.
Publicado: (2014)

Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives
por: Sahila, Mohammed Marunnan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s07karh8jor5ec9c4io3mtm7cg